Austedo (Teva Neuroscience, Inc.)
Welcome to the PulseAid listing for the Austedo drug offered from Teva Neuroscience, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Neuroscience, Inc. |
| NON-PROPRIETARY NAME: | Deutetrabenazine |
| SUBSTANCE NAME: | DEUTETRABENAZINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-04-12 |
| END MARKETING DATE: | 0000-00-00 |
Austedo HUMAN PRESCRIPTION DRUG Details:
| Item Description | Austedo from Teva Neuroscience, Inc. |
| LABELER NAME: | Teva Neuroscience, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6(mg/1) |
| START MARKETING DATE: | 2017-04-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68546-170_a37dc60b-ba12-4cfa-a95a-93858fbae544 |
| PRODUCT NDC: | 68546-170 |
| APPLICATION NUMBER: | NDA208082 |
Other DEUTETRABENAZINE Pharmaceutical Manufacturers / Labelers:
